Companies in the biopharma sector developing innovative solutions and technologies.
Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.
Salvina Therapeutics is developing novel antibodies targeting TNF to overcome efficacy barriers in inflammatory and autoimmune diseases.
Epigene Labs designs genomics-driven drug for precision oncology.
Convexa delivers digital voice assistants with recommendations for life science companies who need to increase engagement with prescribers.
BioAesthetics transforms lives through advancements in biomaterials.
Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Stane's objective is to mobilize collective wisdom to improve community medicine's performance.
Porosome Therapeutics is a biotech company that offers a membrane technology platform to treat diseases.
Blended BioHealth is a biopharmaceutical company.
Mikrobiomik is a biopharmaceutical company that provides innovative solutions for chronic diseases.
Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.
Mariana Oncology is a biotechnology research industry.
Protein eye drop developer for ocular surface diseases
Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare.
CCM Biosciences operates as a biopharmaceutical company.
Ceramedix Holding is a biotherapeutics company that develops antibody-based drugs with the aim of addressing novel diseases.
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
AI-powered multi-omics platform for breakthrough genetic insights
ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked